Skip to contentR
Rigel Pharmaceuticals Inc
R
RIGLRigel Pharmaceuticals Inc Released May 3, 2016, after the close
10-Q filed May 3, 2016, 33 days after period end · 0001558370-16-005199
Q1 2016 · 10-Q
Revenue—
Net income—
EPS Diluted-$0.19-$0.19N/M vs Q1 2015 No earnings release is on file for this quarter. Its figures came with the 10-Q.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
N/M vs Q4 2015
Operating Income-$17,567,000N/M Operating Cash Flow-$22,420,000N/M Free Cash Flowderived-$22,741,000N/M ended Mar 31, 2016 · filed May 3, 2016 · 33 d after period end
7.3% from the close of May 3, 2016 to the close of May 4, 2016, the first after the release.
after the close$2.74$2.54 Apr 1May 3May 31